Skip to content
Demonopol

Legal

Terms, privacy, and risk disclosure.

Three documents. We publish them on the same page so you can read them together. Each section below is a placeholder while counsel finalises the binding text — the live versions land before the first paid Diagnostic.

Section 1

Terms of Service

Pre-launch placeholder

Counsel-reviewed text pending. The points below summarise our intent so you know what to expect when the binding version publishes.

  • Operating entity is Demonopol LLC, registered in St. Vincent and the Grenadines (Co. No. 4008 LLC).
  • Self-Check is provided free of charge with no obligation on either side.
  • The Diagnostic is a fixed-fee one-time service ($400 USD) covered by a 15-minute money-back guarantee.
  • Mandate and Express engagements are scoped per asset under a separate written agreement.
  • We are not a law firm, broker-dealer, or registered investment advisor in any jurisdiction.
  • Tokenization, where pursued, is executed through arms-length partners and remains subject to the laws of the relevant jurisdiction.

Section 2

Privacy Policy

Pre-launch placeholder

Counsel-reviewed text pending. The points below summarise our intended handling of personal data.

  • We collect only the information you provide through the Self-Check, the Diagnostic intake, and direct correspondence.
  • Submission metadata: timestamp, hashed IP (one-way, with a salt — we cannot reverse it to your IP), user-agent string, and referring URL.
  • We do not sell data. We do not share data with third parties except the operational tools needed to run the service (email, payments, scheduling).
  • We do not run cookie-based tracking or third-party advertising scripts.
  • You can ask us to delete your record at any time by emailing legal@demonopol.com — we comply within ten business days.
  • Data is processed in the European Union (Vercel, our email provider). Cross-border transfers occur only as required to run the service.

Section 3

Risk Disclosure

Pre-launch placeholder

Tokenizing private real estate is a newer mechanism. We say so out loud. The points below are the risks we surface in every Diagnostic — the binding text below will be at least this honest.

  • Regulatory risk — the legal treatment of tokenized real estate is evolving across jurisdictions. What's permitted today may not be tomorrow, and vice versa.
  • Liquidity risk — secondary markets for fractional real-estate interests are thin and often venue-specific. Liquidity is improved versus a sole-owner sale, not guaranteed.
  • Operational risk — execution depends on third-party legal, custody, and distribution providers. We name them in your Diagnostic so you can do your own diligence.
  • Valuation risk — pricing private real estate is judgmental. Tokenization does not produce a continuous market price the way listed equities do.
  • Tax risk — treatment differs by jurisdiction, asset class, and investor type. We route to a tax partner — we do not provide tax opinions ourselves.
  • Concentration risk — fractionalization spreads ownership but does not diversify the underlying asset. The asset's risks remain the asset's risks.
  • We do not promise outcomes. We promise process, written deliverables, and an honest read of feasibility.

Questions on any of the three documents: legal@demonopol.com.